The prevalence of nonalcoholic liver steatosis in patients with type 2 diabetes mellitus in the Czech Republic

The prevalence of nonalcoholic liver steatosis in patients with type 2 diabetes mellitus in the Czech Republic

Aims: Nonalcoholic fatty liver disease (NAFLD) is associated with components of the metabolic syndrome (MS) but the prevalence of NAFLD in the Czech Republic is unknown. The aim of this study was to assess the latter in patients with type 2 diabetes (DM2) and to compare the noninvasive fibrosis scor...

Full description

Bibliographic Details
Main Authors:	Karel Dvorak, Radvan Hainer, Jaromir Petrtyl, Miroslav Zeman, Tomas Vareka, Ales Zak, Renata Sroubkova, Tomislav Svestka, Libor Vitek, Radan Bruha
Format:	Article
Language:	English
Published:	Palacký University Olomouc, Faculty of Medicine and Dentistry 2015-09-01
Series:	Biomedical Papers
Subjects:	non-alcoholic fatty liver disease steatosis fibrosis cirrhosis metabolic syndrome type 2 diabetes mellitus
Online Access:	https://biomed.papers.upol.cz/artkey/bio-201503-0018_The_prevalence_of_nonalcoholic_liver_steatosis_in_patients_with_type_2_diabetes_mellitus_in_the_Czech_Republic.php

Similar Items

Nonalcoholic fatty liver disease: Noninvasive methods of diagnosing hepatic steatosis
by: Rasha AlShaalan, et al.
Published: (2015-01-01)

Use of non-invasive parameters of non-alcoholic steatohepatitis and liver fibrosis in daily practice--an exploratory case-control study.
by: Karel Dvorak, et al.
Published: (2014-01-01)

Effects of L-Carnitine and N-Acetylcysteine on nonalcoholic hepatic steatosis in rats
by: Cemal Nas, et al.
Published: (2019-06-01)

Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
by: Sebastian Zenovia, et al.
Published: (2021-04-01)

Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver disease
by: Yingfei Xi, et al.
Published: (2020-01-01)

Alcohol and Steatosis: The Japanese Paradox
by: A. Lonardo, et al.
Published: (2016-06-01)

Steatosis and Steatohepatitis: Complex Disorders
by: Kira Bettermann, et al.
Published: (2014-06-01)

Therapeutic Effects of Garlic on Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial
by: Soleimani D, et al.
Published: (2020-07-01)

Liver steatosis in brain death donors
by: D. V. Voronov, et al.
Published: (2021-04-01)

Atherogenic dyslipidemia and insulin resistance associated with nonalcohol hepatic steatosis: comparison, contrast, and differentiated therapy
by: L. B. Lazebnik, et al.
Published: (2009-06-01)

Alcohol and HBV synergistically promote hepatic steatosis
by: Zhan-Ming Li, et al.
Published: (2019-11-01)

The interaction between nonalcoholic steatosis, anthropometric indicators and disturbance of lipid peroxidation and antioxidant defense in patients with signs of obesity
by: Filippova A.Yu.
Published: (2016-12-01)

The interaction between nonalcoholic steatosis, anthropometric indicators and disturbance of lipid peroxidation and antioxidant defense in patients with signs of obesity.
by: A. Yu. Filippova
Published: (2017-01-01)

Risk Factors for Hepatic Steatosis in Children
by: Yu.M. Stepanov, et al.
Published: (2016-04-01)

Recent Advances in the Assessment of Hepatic Steatosis
by: V.I. Didenko
Published: (2015-09-01)

Hepatocyte-specific PKCβ deficiency protects against high-fat diet-induced nonalcoholic hepatic steatosis
by: Yaoling Shu, et al.
Published: (2021-02-01)

Clinical and sonographic features of the pancreatic steatosis in children with overweight and obesity
by: Yu.M. Stepanov, et al.
Published: (2017-11-01)

Clinical and Anamnestic Features of Hepatic Steatosis in Children
by: N.Yu. Zavgorodnia, et al.
Published: (2015-11-01)

Evaluation of Hepatic Steatosis in Rodents by Time-Domain Nuclear Magnetic Resonance
by: João A.B. Pedroso, et al.
Published: (2019-11-01)

Role of hypothyroidism in the onset of metabolic syndrome and hepatic steatosis
by: Jandrić-Kočič Marijana
Published: (2019-01-01)

Hepatic Steatosis and TNF-?? Signaling
by: Modi, Nita
Published: (2007)

Diagnostic significance of the newest biomarkers of steatosis progression in patients with stable coronary heart disease, combined with nonalcoholic fatty liver disease
by: I. I. Vakalyuk, et al.
Published: (2018-03-01)

Diagnosis and quantification of fibrosis, steatosis, and hepatic siderosis through multiparametric magnetic resonance imaging
by: M. Stoopen-Rometti, et al.
Published: (2017-01-01)

Autophagy in Hepatic Steatosis: A Structured Review
by: Vitor de Miranda Ramos, et al.
Published: (2021-04-01)

Mining Public Toxicogenomic Data Reveals Insights and Challenges in Delineating Liver Steatosis Adverse Outcome Pathways
by: Mohamed Diwan M. AbdulHameed, et al.
Published: (2019-10-01)

Biochemical Markers of Lipid Metabolism Disorders in Children with Hepatic Steatosis
by: N.Yu. Zavhorodnia, et al.
Published: (2015-11-01)

Pancreatic steatosis in children. Part 1. Etiology, epidemiology and pathogenesis
by: Yu.M. Stepanov, et al.
Published: (2017-02-01)

Prevalence and Clinical Characteristics of Nonalcoholic Liver Disease in Type 2 Diabetes Mellitus Patients: A Crosssectional Study
by: Lakshmi Ravansamudram Hariharan, et al.
Published: (2021-04-01)

Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease
by: Shan Li, et al.
Published: (2018-06-01)

Attenuation Imaging with Ultrasound as a Novel Evaluation Method for Liver Steatosis
by: Po-Ke Hsu, et al.
Published: (2021-03-01)

Steatometry and elastometry as methods of noninvasive diagnostics of pancreatic steatosis and fibrosis in children
by: Yu.M. Stepanov, et al.
Published: (2017-04-01)

Treatment of nonalcoholic fatty liver disease
by: Paul Angulo, MD
Published: (2002-01-01)

Pancreatic steatosis in children. Part 2. Risk factors, diagnostic possibilitiess and therapy
by: Yu.M. Stepanov, et al.
Published: (2017-04-01)

Non-invasive monitoring of hepatic steatosis via acoustic structure quantification of ultrasonography with MR spectroscopy as the reference standard
by: Dong Ho Lee, et al.
Published: (2020-01-01)

Activation of a Specific Gut Bacteroides-Folate-Liver Axis Benefits for the Alleviation of Nonalcoholic Hepatic Steatosis
by: Shanshan Qiao, et al.
Published: (2020-08-01)

Morphometric analysis of hepatic steatosis in chronic hepatitis C infection
by: Zubair Alia, et al.
Published: (2009-01-01)

Diethanolamine-Induced Hepatic Steatosis in Mice and Its Amelioration by Curcumin
by: Doctor Hetal I., et al.
Published: (2019-06-01)

The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD)
by: Ziwen Wang, et al.
Published: (2020-06-01)

Magnetic resonance‐based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Cyrielle Caussy, et al.
Published: (2020-10-01)

Comparison of the prevalence, severity, and risk factors for hepatic steatosis in HIV-infected and uninfected people
by: Jessie Torgersen, et al.
Published: (2019-04-01)

Cannot write session to /tmp/vufind_sessions/sess_givemt4idcpp8t8692hiotdu5t